The mTOR pathway in the antiphospholipid syndrome-Reference-Cited by-同舟云学术

The mTOR pathway in the antiphospholipid syndrome

Published:2023-09-21 Issue:6 Volume:3 Page:511-513
ISSN:2749-9642
Container-title:Medical Review
language:en
Short-container-title:

Author:

Ji Lanlan¹,Zhang Zhuoli¹^ORCID,Perl Andras²^ORCID

Affiliation:

1. Department of Rheumatology and Clinical Immunology , Peking University First Hospital , Beijing , China

2. Departments of Medicine, Microbiology and Immunology, Biochemistry and Molecular Biology, Division of Rheumatology and Clinical Immunology , State University of New York, UMU, College of Medicine , Syracuse , NY , USA

Abstract

Abstract This perspective discussed the available evidence on the involvement of mTOR pathway in antiphospholipid syndrome (APS), from the aspects of endothelial cells, platelets, monocytes and anti-phospholipid antibodies (PLs), which may lead to future therapeutic applications of mTOR inhibition in APS.

Publisher

Walter de Gruyter GmbH

Link

https://www.degruyter.com/document/doi/10.1515/mr-2023-0033/pdf

Reference18 articles.

1. Perl, A. Activation of mTOR (mechanistic target of rapamycin) in rheumatic diseases. Nat Rev Rheumatol 2016;12:169–82. https://doi.org/10.1038/nrrheum.2015.172.

2. Garcia, D, Erkan, D. Diagnosis and management of the antiphospholipid syndrome. N Engl J Med 2018;378:2010–21. https://doi.org/10.1056/nejmra1705454.

3. Rodríguez, CM, Velásquez-Berrío, M, Rúa, C, Viana, M, Abrahams, VM, Cadavid, AP, et al.. Antiphospholipid antibodies from women with pregnancy morbidity and vascular thrombosis induce endothelial mitochondrial dysfunction, mTOR activation, and autophagy. Front Physiol 2021;12:706743. https://doi.org/10.3389/fphys.2021.706743.

4. Canaud, G, Bienaimé, F, Tabarin, F, Bataillon, G, Seilhean, D, Noël, LH, et al.. Inhibition of the mTORC pathway in the antiphospholipid syndrome. N Engl J Med 2014;371:303–12. https://doi.org/10.1056/nejmoa1312890.

5. Sevim, E, Siddique, S, Chalasani, MLS, Chyou, S, Shipman, WD, O’Shea, O, et al.. Mammalian target of rapamycin pathway assessment in antiphospholipid antibody–positive patients with livedo. J Rheumatol 2022;49:1026–30. https://doi.org/10.3899/jrheum.220049.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interaction of antiphospholipid antibodies with endothelial cells in antiphospholipid syndrome;Frontiers in Immunology;2024-07-09

2. Biological markers of high risk of thrombotic recurrence in patients with antiphospholipid syndrome: A literature review;Autoimmunity Reviews;2024-06